INTRODUCTION
Hematopoiesis proceeds through the differentiation of stem cells into a cascade of committed progenitors, and finally, into all of the terminally differentiated cell lineages of the blood system.
At least in C57Bl/6 and other Ly-6.2 mouse strains, the cell surface phenotype of the HSC and primitive progenitors has been well elucidated. One of the markers whose expression defines the HSC and various developmental intermediates is the glycosyl phosphatidylinositol-anchored protein (GPI-AP) Sca-1 (for Stem Cell Antigen-1 
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cells fulfill the criteria of HSC, as they are unable to give rise to short-term repopulating cells but are able to provide long-term repopulation of lethally irradiated mice, including secondary and tertiary transplantations 1, 2 . Sca-1 is regulated in a complex fashion during hematopoietic differentiation. As HSCs differentiate into common lymphoid progenitors (CLPs) that give rise to T, B and NK cells but not myeloid lineages, Sca-1 and Kit expression decreases while IL-7R expression increases 3 . Sca-1 and another Ly-6 gene family member, Sca-2, are upregulated on pro-thymocytes which seed the thymic cortex 4 . Sca-1 expression is turned off at an early stage of thymocyte differentiation and is re-expressed by mature single-positive medullary thymocytes and peripheral T cells 5 . Transgenic overexpression of Sca-1 during all stages of thymocyte development arrests development at the CD3 -4 -8 -44 + 25 + stage, the stage in the thymic cortex when Sca-1 expression normally ceases 5 . Concurrent with differentiation of the HSCs into common myeloid progenitors (CMPs), Sca-1 expression is down-regulated 6 . Sca-1 expression is activated in a proportion of CFU-S and CFU-C progenitors 7 .
All functional analysis of Sca-1 has been performed in primary lymphocytes or lymphoid cell lines. The Sca-1 protein (or Ly-6A for Lymphocyte activation protein-6A) was originally identified as an antigen upregulated on activated lymphocytes 8 . GPI-AP are believed to facilitate cell signaling by creating glycoshingolipid cholesterol "rafts" that concentrate or exclude specific signaling molecules 9, 10 . Consistent with this mechanism, Src family kinase members have been shown to associate with Sca-1 11 . Several members of the Ly-6 gene family, which share similar structural motifs as well as primary sequence, have identified cognate ligands, such as the protein CD59 which protects cells from complement mediated lysis by binding the -chain of complement 8 and the "b" domain of complement 9 (ref 12 ). CD59 does not simply act to block the complement cascade, but induces a signaling cascade, which includes activation of the Src family kinase protein Hck, the adapter Shc, and Syk following ligand binding 13 . Thus, it has long been believed that Sca-1 function is dependent upon interaction with its cognate ligand.
Consistent with the expectation that Sca-1 functions as a receptor, an antibody to a 66-kDa GPI-AP immunoprecipitates Sca-1 14 ; however, the identity of the purported 66-kDa ligand has yet to be published. 
MATERIALS AND METHODS

Animals
Antibodies
Purified rat anti-mouse mAbs for flow cytometry were all purchased from BD PharMingen (San Diego, CA). The following mAbs conjugated with either FITC or PE were used: anti-CD3 , anti-
Thy-1, anti-Kit, anti-IL-7R , anti-Sca-1, and anti-TER-119. In some experiments, allophycocyanin conjugated anti-Gr-1 (Ly-6G) and anti-Kit were used. The appropriate conjugated rat anti-mouse mAbs were used as negative controls.
Cytokines
Purified thrombopoietin (rhTPO), rhIL-6, and rhIL-11 were purchased from PeproTech (Rocky Hill, NJ). Purified rhIL-7 was purchased from Stem Cell Technologies, and rmIL-3 was purchased from BD PharMingen.
Flow Cytometry
Single cell suspensions were prepared from bone marrow (tibial and femoral). The bone marrow was subjected to RBC lysis with ammonium chloride, washed once in Iscove's DMEM, counted and resuspended in PBS plus 2% FBS (SM) at 5x10 6 cells/mL. 10 6 cells were incubated with mAbs for 30 min., washed twice in SM and resuspended in 0.2mL SM for analysis using a
Becton Dickinson FACScalibur TM (Mountain View, CA).
Glucose Phosphate Isomerase 1 (Gpi1) Isoenzyme Analysis
The samples were subjected to electrophoresis on cellulose acetate plates (Helena Laboratories), and the Gpi1 isoenzyme bands were visualized as previously described 22 . The contribution of mutant cells to the samples was visually estimated by comparison to a set of standard mixtures of Gpi1-AA and Gpi1-BB cells.
Hematological Analysis
Peripheral blood (50-100µL) from tail bleeds was collected into EDTA coated capillary pipets (Drummond) and transferred to eppendorf tubes. Complete blood counts and differential counts were performed using a Coulter Ac-T Differential Hematology Analyzer with veterinary software (Beckman-Coulter).
Bleeding Time Assay
Six to 8 week old mice were anesthetized using 0.15mg/g body weight ketamine to reduce influences by heart rate and activity on bleeding time. Approximately a 3-mm portion of the tail was cleanly severed using scissors. The tail was immersed in physiological saline at 37°C. The time required for the small stream of blood to stop was recorded as the bleeding time.
CFU-C
For each experiment, three animals of each genotype were used. Each experiment was performed between three and eight times. Single cell suspensions were prepared from bone marrow (tibial and grown in humidified chambers at 37°C, 5% CO 2 . To assay CFU-megakaryocyte (CFU-Mk), cells were grown in methylcellulose/collagen media (Stem Cell Technologies) containing 50ng/ml rhTPO, 10ng/ml rmIL-3, 20ng/ml rhIL-6, and 50ng/ml rhIL-11, and visualized by acetylcholinesterase activity. All other CFU-C were grown in methylcellulose containing IL-3, IL-6, SLF, and EPO (M3434, Stem Cell Technologies). CFU-E were assayed after 2 days by staining in situ with benzidine (Sigma) to detect hemoglobin. BFU-E and CFU-C were counted after 7-10 days by colony morphology. Representative colonies were occasionally analyzed by
Wright-Giemsa to confirm colony identity.
CFU-S
The results shown are combined from 3 separate experiments. For each experiment, the bone marrow from three mice of the same genotype was combined. Single cell suspensions were prepared from bone marrow flushed from both tibiae and femurs and diluted to 10 5 cells/ml. were then subjected to iso-osmotic Percoll (Pharmacia) centrifugation. The density (1.077g/ml) separated donor bone marrow cells (or "buffy coat") were then mixed at the following ratios for Percoll separated bone marrow cells were injected into the tail veins of three lethally irradiated mice of the same genotype (and Gpi1 isotype) as the primary recipient.
RESULTS
Hematological Analysis
To minimize genetic background affects on the analysis of the role of Sca-1 in hematopoiesis, we backcrossed the Sca-1 targeted null allele onto the C57Bl/6 background for 10 generations.
Theoretically, the entire genetic background of these animals is derived from the C57Bl/6 strain with the exception of approximately 20 cM flanking the Ly-6 locus that is derived from the 129 ES cell line used for gene targeting 19 . The backcross 10 mice were bred to generate Sca-1+/+
and Sca-1-/-progeny, which were subsequently independently bred. Hematopoietic analysis of Sca-1-/-mice began with automated peripheral blood counts ( Table 1 ). The hematocrits, hemoglobin, total RBC and WBC counts were similar between Sca-1+/+ and Sca-1-/-mice. Yet, the percentages among the peripheral WBC were significantly altered in Sca-1-/-mice (P<0.05).
The percentage of peripheral blood lymphocytes was increased with a concomitant decrease in both monocytes and granulocytes. These results are consistent with our previous report that showed a reduction in megakaryocytes (data not shown).
To determine if the defective megakaryopoiesis resulted in a physiological defect, bleeding times in response to tail cuts were measured on Sca-1+/+ and Sca-1-/-mice. A 69% increase in average bleeding time was observed for Sca-1-/-mice; however, the results were not statistically significant due to the large variation in bleeding times in both wild type and mutant mice (data not shown). The limited increase in bleeding time is consistent with the mild thrombocytopenia observed in Sca-1-/-mice.
Precursor Analysis
Colony forming assays were performed to analyze the role of Sca-1 in the development of myeloid committed precursors. The most primitive in vitro colony forming cells (CFU-GEMM)
were reduced by more than 60%. As expected by the four-fold decrease in bone marrow megakaryocytes, there was also a substantial decrease in megakaryocyte precursors (CFU-Mk) in
Sca-1-/-bone marrow (Table 3) 
Serial Transplantations
HSC self-renewal activity was analyzed using serial transplantation of Sca-1-/-bone marrow into wild type Gpi1AA mice and wild type Gpi1AA bone marrow into Sca-1-/-mice (Fig. 3) . As shown in Figures 2 and 3 (Figure 4) 
DISCUSSION
The data presented here demonstrate that Sca-1 plays an important role in regulating the repopulating ability of HSCs and the development of committed progenitor cells, megakaryocytes and platelets. The decrease in CFU-S and CFU-GEMM may be attributable to deficient stem cell self-renewal and differentiation observed by the repopulation assays. The simplest explanation for the dramatic reduction in Sca-1-/-HSC repopulating ability between primary and secondary BM transplantations is that Sca-1 plays an important role in HSC selfrenewal, at least in response to hematological stress caused by lethal irradiation and transplantation. This explanation is consistent with the regulation of Sca-1 by interferons 25, 26 and TNF 27 which are known to be induced in response to cellular stress; poor competition of
Sca-1-/-HSCs with wild type stem cells in primary transplantations but not a complete lack of
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